Abbott Labs Pulls Obesity Drug Over Heart Risk
The obesity drug Meridia has been withdrawn from the U.S. market because of an increased risk of heart attack and
Read moreThe obesity drug Meridia has been withdrawn from the U.S. market because of an increased risk of heart attack and
Read moreThe controversial diabetes drug Avandia does raise the risk of heart attack more than other medications of its kind but
Read more